“…Nevertheless, with no clear reason, a sharp increase was observed in N 51 R 59 N 108 I 164 /S 436 G 437 haplotype from 2010 to 2014, which is the same as what was reported from Northeastern India (Mishra et al, 2014). The predominant pfdhfr haplotype in Iran seems to be N51,59R,108N rather than 51I,59R,108N similar to the previous reports from Afghanistan (Awab et al, 2013), Pakistan (Khatoon et al, 2009;Ghanchi et al, 2011;Kolaczinski et al, 2012), India (Biswas et al, 2000;Ahmed et al, 2004;Garg et al, 2009), Sri Lanka (Hapuarachchi et al, 2006), and Papua New Guinea (Mita et al, 2006). Therefore, mutation 51I might be a good molecular marker for rapid detection of triple mutant, showing pyrimethamine failure in Iran and its neighboring countries, Afghanistan and Pakistan.…”